Board of Scientific Counselors, National Center for Injury Prevention and Control, 16634 [2023-05638]
Download as PDF
<![CDATA[
16634
Federal Register / Vol. 88, No. 53 / Monday, March 20, 2023 / Notices
the comments and will use them to help
disseminate and implement the plan.
Dated: March 15, 2023.
John J. Howard,
Director, National Institute for Occupational
Safety and Health, Centers for Disease Control
and Prevention.
[FR Doc. 2023–05602 Filed 3–17–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Center for Injury Prevention
and Control
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with regulatory
provisions, the Centers for Disease
Control and Prevention (CDC)
announces the following meeting for the
Board of Scientific Counselors, National
Center for Injury Prevention and Control
(BSC, NCIPC or Board). This meeting is
partially open to the public.
DATES: The meeting will be held on May
3, 2023, from 1 p.m. to 3 p.m., EDT
(CLOSED); and May 4, 2023, from 9:30
a.m. to 3:30 p.m., EDT (OPEN). The
public comment period will be at the
end of the open session of the meeting
on May 4, 2023, from 3:10 p.m. to 3:25
p.m., EDT.
ADDRESSES: Webinar, Atlanta, Georgia.
All participants must register by using
the following link to attend the open
session: https://cdc.zoomgov.com/
meeting/register/vJIsfuqtrT4pE4H6oCKSs9t2KHS69o3yHo.
FOR FURTHER INFORMATION CONTACT:
Christopher R. Harper, Ph.D., Senior
Epidemiologist, National Center for
Injury Prevention and Control, Centers
for Disease Control and Prevention,
4770 Buford Highway NE, Mailstop S–
1069, Atlanta, Georgia 30341.
Telephone: (404) 718–8330; Email:
ncipcbsc@cdc.gov.
SUPPLEMENTARY INFORMATION: Portions
of the meeting referenced above will be
closed to the public in accordance with
provisions set forth in section 552b(c)(4)
and (6), title 5 U.S.C., and the
Determination of the Director, Strategic
Business Initiatives Unit, Office of the
Chief Operating Officer, CDC, pursuant
to Public Law 92–463 (5 U.S.C. 1009),
as amended.
Purpose: The Board of Scientific
Counselors, National Center for Injury
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
17:19 Mar 17, 2023
Jkt 259001
Prevention and Control (BSC, NCIPC or
Board) will: (1) conduct, encourage,
cooperate with, and assist other
appropriate public health authorities,
scientific institutions, and scientists in
the conduct of research, investigations,
experiments, demonstrations, and
studies relating to the causes, diagnosis,
treatment, control, and prevention of
physical and mental diseases, and other
impairments; (2) assist States and their
political subdivisions in preventing and
suppressing communicable and noncommunicable diseases and other
preventable conditions and in
promoting health and well-being; and
(3) conduct and assist in research and
control activities related to injury. The
BSC, NCIPC makes recommendations
regarding policies, strategies, objectives,
and priorities; reviews progress toward
injury prevention goals; and provides
evidence in injury prevention-related
research and programs. The Board also
provides advice on the appropriate
balance of intramural and extramural
research, as well as the structure,
progress, and performance of intramural
programs. The Board provides guidance
on extramural scientific program
matters, including the: (1) review of
extramural research concepts for
funding opportunity announcements;
(2) conduct of Secondary Peer Review of
extramural research grant applications,
cooperative agreement applications, and
contract applications received in
response to funding opportunity
announcements as they relate to the
Center’s programmatic balance and
mission; (3) submission of secondary
review recommendations to the Center
Director of applications to be considered
for funding support; (4) review of
research portfolios; and (5) review of
program proposals.
Matters To Be Considered: The closed
session of the meeting (Day 1) will focus
on the Secondary Peer Review of
extramural research grant applications
received in response to two (2) Notices
of Funding Opportunity: RFA–CE–20–
001—‘‘Evaluating Practice-based
Programs, Policies, and Practices from
CDC’s Rape Prevention and Education
(RPE) Program: Expanding the Evidence
to Prevent Sexual Violence (U01)’’; and
RFA–CE–23–008—‘‘Research Grants to
Develop and Validate a Prognostic Tool
of Mental Health Sequelae After
Traumatic Brain Injury for Adolescent
Patients’’ (U01).’’ The open session of
the meeting (Day 2) will include
discussions on Improving the Quality
and Reach of Extramural Research
Notices of Funding Opportunity;
Updated and Expanded CDC Guidance
for the Identification and Response of
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
Suicide Clusters; Developing a Cascade
of Care Framework and Surveillance
Indicators to Measure Linkage and
Retention to Care for Substance Use
Disorders; and Moving Science and Data
to Violence Prevention Action. Agenda
items are subject to change as priorities
dictate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2023–05638 Filed 3–17–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers: CMS–10488]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of
SUMMARY:
E:\FR\FM\20MRN1.SGM
20MRN1
]]>Agencies
[Federal Register Volume 88, Number 53 (Monday, March 20, 2023)]
[Notices]
[Page 16634]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-05638]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, National Center for Injury
Prevention and Control
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with regulatory provisions, the Centers for
Disease Control and Prevention (CDC) announces the following meeting
for the Board of Scientific Counselors, National Center for Injury
Prevention and Control (BSC, NCIPC or Board). This meeting is partially
open to the public.
DATES: The meeting will be held on May 3, 2023, from 1 p.m. to 3 p.m.,
EDT (CLOSED); and May 4, 2023, from 9:30 a.m. to 3:30 p.m., EDT (OPEN).
The public comment period will be at the end of the open session of the
meeting on May 4, 2023, from 3:10 p.m. to 3:25 p.m., EDT.
ADDRESSES: Webinar, Atlanta, Georgia. All participants must register by
using the following link to attend the open session: https://cdc.zoomgov.com/meeting/register/vJIsfuqtrT4pE4H6-oCKSs9t2KHS69o3yHo.
FOR FURTHER INFORMATION CONTACT: Christopher R. Harper, Ph.D., Senior
Epidemiologist, National Center for Injury Prevention and Control,
Centers for Disease Control and Prevention, 4770 Buford Highway NE,
Mailstop S-1069, Atlanta, Georgia 30341. Telephone: (404) 718-8330;
Email: [email protected].
SUPPLEMENTARY INFORMATION: Portions of the meeting referenced above
will be closed to the public in accordance with provisions set forth in
section 552b(c)(4) and (6), title 5 U.S.C., and the Determination of
the Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to Public Law 92-463 (5 U.S.C. 1009),
as amended.
Purpose: The Board of Scientific Counselors, National Center for
Injury Prevention and Control (BSC, NCIPC or Board) will: (1) conduct,
encourage, cooperate with, and assist other appropriate public health
authorities, scientific institutions, and scientists in the conduct of
research, investigations, experiments, demonstrations, and studies
relating to the causes, diagnosis, treatment, control, and prevention
of physical and mental diseases, and other impairments; (2) assist
States and their political subdivisions in preventing and suppressing
communicable and non-communicable diseases and other preventable
conditions and in promoting health and well-being; and (3) conduct and
assist in research and control activities related to injury. The BSC,
NCIPC makes recommendations regarding policies, strategies, objectives,
and priorities; reviews progress toward injury prevention goals; and
provides evidence in injury prevention-related research and programs.
The Board also provides advice on the appropriate balance of intramural
and extramural research, as well as the structure, progress, and
performance of intramural programs. The Board provides guidance on
extramural scientific program matters, including the: (1) review of
extramural research concepts for funding opportunity announcements; (2)
conduct of Secondary Peer Review of extramural research grant
applications, cooperative agreement applications, and contract
applications received in response to funding opportunity announcements
as they relate to the Center's programmatic balance and mission; (3)
submission of secondary review recommendations to the Center Director
of applications to be considered for funding support; (4) review of
research portfolios; and (5) review of program proposals.
Matters To Be Considered: The closed session of the meeting (Day 1)
will focus on the Secondary Peer Review of extramural research grant
applications received in response to two (2) Notices of Funding
Opportunity: RFA-CE-20-001--``Evaluating Practice-based Programs,
Policies, and Practices from CDC's Rape Prevention and Education (RPE)
Program: Expanding the Evidence to Prevent Sexual Violence (U01)''; and
RFA-CE-23-008--``Research Grants to Develop and Validate a Prognostic
Tool of Mental Health Sequelae After Traumatic Brain Injury for
Adolescent Patients'' (U01).'' The open session of the meeting (Day 2)
will include discussions on Improving the Quality and Reach of
Extramural Research Notices of Funding Opportunity; Updated and
Expanded CDC Guidance for the Identification and Response of Suicide
Clusters; Developing a Cascade of Care Framework and Surveillance
Indicators to Measure Linkage and Retention to Care for Substance Use
Disorders; and Moving Science and Data to Violence Prevention Action.
Agenda items are subject to change as priorities dictate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-05638 Filed 3-17-23; 8:45 am]
BILLING CODE 4163-18-P
